Zamann Pharma Support delivers expert consulting services focused on developing a complete Nitrosamines Analytical Strategy for pharmaceutical companies. Our approach includes designing SOPs, guiding validation protocols, and establishing quality control systems to ensure full compliance with ICH M7 and FDA requirements. We help clients build robust analytical workflows that address the complexity of detecting and quantifying nitrosamines in various drug matrices. With a focus on data integrity, regulatory alignment, and scientific accuracy, our strategies enable consistent performance, defendable documentation, and reliable results during both internal audits and health authority inspections.
An essential part of a compliant Nitrosamines Analytical Strategy is the creation of structured and actionable SOPs. We collaborate with clients to define procedures tailored to their laboratory setup, analytical challenges, and regulatory exposure. Our SOPs include detailed instructions for sample preparation, instrumental setup (e.g., LC-MS, GC-MS), calibration standards, peak identification, and reporting protocols. All documents are designed to align with ICH M7, FDA, and GxP expectations. Our goal is to ensure laboratories have inspection-ready procedures that ensure reproducibility, minimize variability, and promote consistent, validated nitrosamine detection across all product types.
Method validation is a cornerstone of a sound Nitrosamines Analytical Strategy. We provide step-by-step support for designing and executing validation protocols that meet regulatory standards and suit complex drug product matrices. Our team advises on selecting appropriate reference standards, setting acceptance criteria, and structuring validation plans that demonstrate specificity, accuracy, precision, linearity, and robustness. We also focus on ensuring complete traceability of raw data and adherence to ALCOA+ principles. Clients benefit from a thorough validation package that supports regulatory filings and withstands scrutiny from global authorities during routine and for-cause inspections.
To ensure long-term success of the Nitrosamines Analytical Strategy, we help clients implement risk-based quality control measures. This includes defining critical quality attributes (CQAs), setting alert and action limits, and implementing trend monitoring procedures. We provide guidance on routine calibration and preventive maintenance plans for high-sensitivity instruments used in nitrosamine detection. Our experts support the integration of periodic system suitability tests, performance metrics dashboards, and root cause analysis protocols. The result is a dynamic QC framework that improves result reliability, enables proactive issue resolution, and reinforces a culture of data-driven analytical excellence.
Our strategic approach to ensure Nitrosamine compliance is based on global and holistic experience, and can be perfectly adapted to your reality. We address the latest regulations and risk assessments, helping you manage and mitigate potential risks specific to your products and processes.
Zamann stays ahead of the evolving Nitrosamine requirements, providing expert guidance to ensure compliance with confidence. Our proactive and senior approach helps protect product integrity and patient safety, securing your operations against regulatory risks.
